Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, August 16 '25)

Image
By G.M.

 


    Antiviral Res

  1. AL KRAD D, Stegmann KM, Dickmanns A, Kumar P, et al
    The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replication.
    Antiviral Res. 2025 Jul 29:106247. doi: 10.1016/j.antiviral.2025.106247.
    PubMed         Abstract available

  2. PATEL D, De R, Azadi N, Lee S, et al
    Discovery of broad-spectrum antivirals targeting viral proteases using in silico structural modeling and cellular analysis.
    Antiviral Res. 2025;241:106245.
    PubMed         Abstract available

  3. LEBEDIN M, Petrovsky N, Tabynov K, Tabynov K, et al
    SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibody.
    Antiviral Res. 2025;241:106235.
    PubMed         Abstract available


    Arch Virol

  4. FERNANDEZ-ROJAS MA, Salazar AM, Ostrosky-Wegman P, Flisser A, et al
    A feedback loop between DNA damage, genomic instability, and cytoplasmic DNA sensing contributes to cytokine production in COVID-19.
    Arch Virol. 2025;170:192.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  5. ZHU H, Chen J, Dong X, Qin X, et al
    Influence of dihydrocaffeic acid and quinic acid on lung metabolism and function: Implications for dietary interventions.
    Biochem Biophys Res Commun. 2025;777:152274.
    PubMed         Abstract available

  6. HODYNA D, Gryniukova A, Rogalsky S, Borysko P, et al
    Ionic liquids and lysosomotropic detergents as inhibitors of the SARS-CoV-2 main protease: QSAR modeling, synthesis and biological testing.
    Biochem Biophys Res Commun. 2025;777:152276.
    PubMed         Abstract available

  7. ZHENG WH, Ni RZ, Ran XH, Mu D, et al
    Papain-like protease of SARS-CoV-2 inhibits dsRNA-induced type I interferon response partly by cleaving TBK1.
    Biochem Biophys Res Commun. 2025;777:152244.
    PubMed         Abstract available


    Cell

  8. HUANG Y, Tan L, Liu Y, Zhao H, et al
    Response to: The mechanism for GTP-mediated RNA capping by the SARS-CoV-2 NiRAN domain remains unresolved.
    Cell. 2025;188:4462-4469.
    PubMed         Abstract available

  9. SMALL GI, Darst SA, Campbell EA
    The mechanism for GTP-mediated RNA capping by the SARS-CoV-2 NiRAN domain remains unresolved.
    Cell. 2025;188:4456-4461.
    PubMed         Abstract available


    Epidemiol Infect

  10. SMAGGE B, Labuschagne L, Pijpers J, van Roon A, et al
    Factors associated with lower COVID-19 vaccine uptake among populations with a migration background in the Netherlands.
    Epidemiol Infect. 2025;153:e87.
    PubMed         Abstract available


    J Infect Dis

  11. ESPERSEN C, Johansen ND, Modin D, Janstrup KH, et al
    Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trial.
    J Infect Dis. 2025 Aug 13:jiaf420. doi: 10.1093.
    PubMed         Abstract available

  12. WONG JY, Cheung JK, Iuliano AD, Wu P, et al
    Influenza-associated excess mortality associated with influenza B in Hong Kong, 2014-2023.
    J Infect Dis. 2025 Aug 6:jiaf414. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  13. YAN Y, Xu J, Chen Z, Xu Y, et al
    Heat shock protein A1L restricts influenza A virus by ubiquitination of NA.
    J Virol. 2025 Aug 11:e0077125. doi: 10.1128/jvi.00771.
    PubMed         Abstract available

  14. KELVIN AA, Baker PH, Ghosh S, Schultz-Cherry S, et al
    Influenza infection of the mammary gland.
    J Virol. 2025 Aug 12:e0194024. doi: 10.1128/jvi.01940.
    PubMed         Abstract available

  15. DZIMIANSKI JV, Nagashima KA, Cruz JM, Sautto GA, et al
    Assessing the structural boundaries of broadly reactive antibody interactions with diverse H3 influenza hemagglutinin proteins.
    J Virol. 2025 Aug 14:e0045325. doi: 10.1128/jvi.00453.
    PubMed         Abstract available


    Pediatrics

  16. ANTOON JW
    Influenza Antivirals: Do We Need More Evidence?
    Pediatrics. 2025 Aug 13:e2025071863. doi: 10.1542/peds.2025-071863.
    PubMed        

  17. BASSETT HK, Rao S, Beck J, Brady PW, et al
    Clinician Preferences for Oseltamivir Use in Children With Influenza in the Outpatient Setting.
    Pediatrics. 2025 Aug 13:e2025071193. doi: 10.1542/peds.2025-071193.
    PubMed         Abstract available


    PLoS Comput Biol

  18. SCIANNA M, Gallotti R, Tizzoni M, Artime O, et al
    Comparing the effectiveness of ring and block-vaccination strategies on networks.
    PLoS Comput Biol. 2025;21:e1013274.
    PubMed         Abstract available

  19. TIZZANI M, Gauvin L
    Socioeconomic determinants of protective behaviors and contact patterns in the post-COVID-19 pandemic era: A cross-sectional study in Italy.
    PLoS Comput Biol. 2025;21:e1013262.
    PubMed         Abstract available


    PLoS One

  20. NAROUEI FH, Tang Z, Wang SI, Hashmi RH, et al
    Effects of germicidal far-UVC on ozone and particulate matter in a conference room.
    PLoS One. 2025;20:e0328224.
    PubMed         Abstract available

  21. WYPLOSZ B, Grenier B, Roche N, Roubille F, et al
    Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.
    PLoS One. 2025;20:e0329703.
    PubMed         Abstract available

  22. SOEDER J, Preiser C, Wagner A, Neunhoffer AT, et al
    Pandemic preparedness in shaping psychosocial working conditions - insights for occupational safety and health from a longitudinal mixed-methods study during the COVID-19 pandemic at six company sites of one organization in Germany.
    PLoS One. 2025;20:e0328410.
    PubMed         Abstract available

  23. BHAGAVATHI V, Ogum D, Agyabeng K, Coker-Appiah D, et al
    Unchanged but undecided: Reproductive intentions among Ghanaian women following COVID-19 lockdowns in two large metropolises in Ghana.
    PLoS One. 2025;20:e0328298.
    PubMed         Abstract available

  24. TOUZET H, Privault S, Ward JK
    The role of professional socialisation in confidence in vaccines and vaccination decision-makers: Insights from a large multi-wave survey in France.
    PLoS One. 2025;20:e0328548.
    PubMed         Abstract available

  25. RASMUSSEN MGB, Just-Ostergaard E, Stidsen JV, Willaing I, et al
    What is the impact of structural changes in society on diabetes self-management and trajectories of HbA1c? A cohort study before, during and after the COVID-19 pandemic in people with diabetes treated at outpatient clinics.
    PLoS One. 2025;20:e0329394.
    PubMed         Abstract available

  26. ROY S, Biswas P, Ghosh P
    Advancing infection profiling under data uncertainty through contagion potential.
    PLoS One. 2025;20:e0329828.
    PubMed         Abstract available

  27. MO J, Ferreri LM, Geiger G, Perez DR, et al
    Passage of human-origin influenza A virus in swine tracheal epithelial cells selects for adaptive mutations in the hemagglutinin gene.
    PLoS One. 2025;20:e0327096.
    PubMed         Abstract available

  28. PRASERT K, Praphasiri P, Ditsungnoen D, Srichaijaroonpong S, et al
    Perceptions of influenza and SARS-CoV-2 vaccination among health care personnel in Thailand, 2024.
    PLoS One. 2025;20:e0329473.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  29. XU Y, Anirudhan V, Gaisina IN, Du H, et al
    Mechanistic insights into the small-molecule inhibition of influenza A virus entry.
    Proc Natl Acad Sci U S A. 2025;122:e2503899122.
    PubMed         Abstract available


    Vaccine

  30. ASHRAF M, Stein AN, Youhanna J, Rockman S, et al
    The impact of egg adaptation and immune imprinting on influenza vaccine effectiveness.
    Vaccine. 2025;62:127393.
    PubMed         Abstract available


    Virology

  31. CHERNYSHOVA AI, Zhirnov OP
    Influenza A virions with uncleaved hemagglutinin HA0 are more resistant to thermal inactivation than those with cleaved HA1/2: Research and applied significance.
    Virology. 2025 Jul 26:110644. doi: 10.1016/j.virol.2025.110644.
    PubMed        
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »